SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Cherie M. Pucheu-Haston, Kaitlin A. Kasparek, Rhett W. Stout, Michael T. Kearney, Bruce Hammerberg, Effects of pentoxifylline on immediate and late-phase cutaneous reactions in response to anti–immunoglobulin E antibodies in clinically normal dogs, American Journal of Veterinary Research, 2014, 75, 2, 152

    CrossRef

  2. 2
    L. J. Kay, M. Gilbert, N. Pullen, S. Skerratt, J. Farrington, E. P. Seward, P. T. Peachell, Characterization of the EP receptor subtype that mediates the inhibitory effects of prostaglandin E2 on IgE-dependent secretion from human lung mast cells, Clinical & Experimental Allergy, 2013, 43, 7
  3. 3
    A. Lewis, J. Wan, B. Baothman, P. N. Monk, S. K. Suvarna, P. T. Peachell, Heterogeneity in the responses of human lung mast cells to stem cell factor, Clinical & Experimental Allergy, 2013, 43, 1
  4. 4
    N. Eskandari, R. Bastan, P.T. Peachell, Regulation of human skin mast cell histamine release by PDE inhibitors, Allergologia et Immunopathologia, 2013,

    CrossRef

  5. You have free access to this content5
    D F Finn, J J Walsh, Twenty-first century mast cell stabilizers, British Journal of Pharmacology, 2013, 170, 1
  6. 6
    Clive P Page, Domenico Spina, Selective PDE inhibitors as novel treatments for respiratory diseases, Current Opinion in Pharmacology, 2012, 12, 3, 275

    CrossRef

  7. 7
    S. Havard, A.-M. Scola, L. J. Kay, S. S. Ishmael, D. W. MacGlashan, P. T. Peachell, Characterization of syk expression in human lung mast cells: relationship with function, Clinical & Experimental Allergy, 2011, 41, 3
  8. 8
    Déborah Mara Costa de Oliveira, Ana Carolina Luchini, Leonardo Noboru Seito, José Carlos Gomes, María Elena Crespo-López, Luiz Claudio Di Stasi, Cordia verbenacea and secretion of mast cells in different animal species, Journal of Ethnopharmacology, 2011, 135, 2, 463

    CrossRef

  9. 9
    Zuzana Diamant, Domenico Spina, PDE4-inhibitors: A novel, targeted therapy for obstructive airways disease, Pulmonary Pharmacology & Therapeutics, 2011, 24, 4, 353

    CrossRef

  10. 10
    Katharina Cima, Helene Vogelsinger, Christian M. Kähler, Sensory neuropeptides are potent chemoattractants for human basophils in vitro, Regulatory Peptides, 2010, 160, 1-3, 42

    CrossRef

  11. 11
    Toshiyuki Kita, Masaki Fujimura, Shigeharu Myou, Kazuyoshi Watanabe, Yuko Waseda, Shinji Nakao, Effects of KF19514, a Phosphodiesterase 4 and 1 Inhibitor, on Bronchial Inflammation and Remodeling in a Murine Model of Chronic Asthma, Allergology International, 2009, 58, 2, 267

    CrossRef

  12. 12
    Miyuki Hori, Takehisa Iwama, Yumiko Asakura, Masafumi Kawanishi, Junji Kamon, Akihiko Hoshino, Shuya Takahashi, Kenzo Takahashi, Shiro Nakaike, Nobutomo Tsuruzoe, NT-702 (parogrelil hydrochloride, NM-702), a novel and potent phosphodiesterase 3 inhibitor, suppress the asthmatic response in guinea pigs, with both bronchodilating and anti-inflammatory effects, European Journal of Pharmacology, 2009, 618, 1-3, 63

    CrossRef

  13. 13
    Neil J. Press, Katharine H. Banner, Progress in Medicinal Chemistry Volume 47, 2009,

    CrossRef

  14. 14
    D Spina, PDE4 inhibitors: current status, British Journal of Pharmacology, 2008, 155, 3
  15. 15
    Carolyn Bauer, Bernhard Przybilla, Bernadette Eberlein, Sevasti Kolsouzidou, Franziska Ruëff, Changes in intracellular cyclic adenosine monophosphate levels in peripheral blood leukocytes during immunotherapy with vespid venom, Annals of Allergy, Asthma & Immunology, 2007, 98, 3, 281

    CrossRef

  16. 16
    Xian Song Wang, Hang Yung Alaster Lau, Histamine release from human buffy coat-derived mast cells, International Immunopharmacology, 2007, 7, 4, 541

    CrossRef

  17. 17
    C A Harrison, R Bastan, M J Peirce, M R Munday, P T Peachell, Role of calcineurin in the regulation of human lung mast cell and basophil function by cyclosporine and FK506, British Journal of Pharmacology, 2007, 150, 4
  18. 18
    Masaki Fujimura, Qi Liu, Selective inhibitors for phosphodiesterase 3 and 4 in antigen-induced increase of cough reflex sensitivity in guinea pigs, Pulmonary Pharmacology & Therapeutics, 2007, 20, 5, 543

    CrossRef

  19. 19
    Xian-song Wang, Sze Wing Sam, Kwok Ho Yip, Hang Yung A. Lau, Functional characterization of human mast cells cultured from adult peripheral blood, International Immunopharmacology, 2006, 6, 5, 839

    CrossRef

  20. 20
    L. Wollin, D.S. Bundschuh, A. Wohlsen, D. Marx, R. Beume, Inhibition of airway hyperresponsiveness and pulmonary inflammation by roflumilast and other PDE4 inhibitors, Pulmonary Pharmacology & Therapeutics, 2006, 19, 5, 343

    CrossRef

  21. 21
    Victoria Boswell-Smith, Domenico Spina, Clive P Page, Phosphodiesterase inhibitors, British Journal of Pharmacology, 2006, 147, S1
  22. 22
    Nahid Eskandari, Thulani Wickramasinghe, Peter T Peachell, Effects of phosphodiesterase inhibitors on interleukin-4 and interleukin-13 generation from human basophils, British Journal of Pharmacology, 2004, 142, 8
  23. 23
    Shin-ya Saito, Yukiko Maruyama, Sachie Kamiyama, Norimichi Nakahata, Yasushi Ohizumi, Ephedrae herba in Mao-Bushi-Saishin-To Inhibits IgE-Mediated Histamine Release and Increases cAMP Content in RBL-2H3 Cells, Journal of Pharmacological Sciences, 2004, 95, 1, 41

    CrossRef

  24. 24
    Emiliano O Barreto, Vinicius F Carvalho, Vincent Lagente, Claire Lugnier, Renato S.B Cordeiro, Marco A Martins, Patrı́cia M.R e Silva, Increased levels of cyclic adenosine monophosphate contribute to the hyporesponsiveness of mast cells in alloxan diabetes, International Immunopharmacology, 2004, 4, 6, 755

    CrossRef

  25. 25
    Daisuke Tenmizu, Yasuhisa Fukunaga, Kiyoshi Noguchi, Hidetaka Kamimura, Simultaneous determination of YM-64227, a phosphodiesterase type 4 inhibitor, and its five metabolites in dog plasma by high-performance liquid chromatography with fluorescence detection, Biomedical Chromatography, 2004, 18, 9
  26. 26
    Hiroshi Moriuchi, Tsutomu Nakahara, Takeshi Maruko, Kenji Sakamoto, Kunio Ishii, Relaxant effect of YM976, a novel phosphodiesterase 4 inhibitor, on bovine tracheal smooth muscle, European Journal of Pharmacology, 2003, 470, 1-2, 57

    CrossRef

  27. 27
    Domenico Spina, Theophylline and PDE4 inhibitors in asthma, Current Opinion in Pulmonary Medicine, 2003, 9, 1, 57

    CrossRef

  28. 28
    Lee K. Chong, Russell Chess-Williams, Peter T. Peachell, Pharmacological characterisation of the β-adrenoceptor expressed by human lung mast cells, European Journal of Pharmacology, 2002, 437, 1-2, 1

    CrossRef

  29. 29
    Lı́dia M Lima, Paulo Castro, Alexandre L Machado, Carlos Alberto M Fraga, Claire Lugnier, Vera Lúcia Gonçalves de Moraes, Eliezer J Barreiro, Synthesis and anti-inflammatory activity of phthalimide derivatives, designed as new thalidomide analogues, Bioorganic & Medicinal Chemistry, 2002, 10, 9, 3067

    CrossRef

  30. 30
    Ruud E. Santing, Jacob de Boer, Astrid Rohof, Nienke M. van der Zee, Johan Zaagsma, Bronchodilatory and anti-inflammatory properties of inhaled selective phosphodiesterase inhibitors in a guinea pig model of allergic asthma, European Journal of Pharmacology, 2001, 429, 1-3, 335

    CrossRef

  31. 31
    David M. Essayan, Cyclic nucleotide phosphodiesterases, Journal of Allergy and Clinical Immunology, 2001, 108, 5, 671

    CrossRef

  32. 32
    Christine Tkaczyk, Alasdair M. Gilfillan, FcεRI-Dependent Signaling Pathways in Human Mast Cells, Clinical Immunology, 2001, 99, 2, 198

    CrossRef

  33. 33
    Myou, Fujimura, Kurashima, Tachibana, Hirose, Nakao, Effect of aerosolized administration of KF19514, a phosphodiesterase 4 inhibitor, on bronchial hyperresponsiveness and airway inflammation induced by antigen inhalation in guinea-pigs, Clinical & Experimental Allergy, 2000, 30, 5
  34. 34
    John E. Souness, David Aldous, Carol Sargent, Immunosuppressive and anti-inflammatory effects of cyclic AMP phosphodiesterase (PDE) type 4 inhibitors, Immunopharmacology, 2000, 47, 2-3, 127

    CrossRef

  35. 35
    Dunja T Schmidt, Nikki Watson, Gordon Dent, Elke Rühlmann, Detlev Branscheid, Helgo Magnussen, Klaus F Rabe, The effect of selective and non-selective phosphodiesterase inhibitors on allergen- and leukotriene C4-induced contractions in passively sensitized human airways, British Journal of Pharmacology, 2000, 131, 8
  36. 36
    David M Essayan, Cyclic nucleotide phosphodiesterase (PDE) inhibitors and immunomodulation, Biochemical Pharmacology, 1999, 57, 9, 965

    CrossRef

  37. 37
    Annette M Doherty, Phosphodiesterase 4 inhibitors as novel anti-inflammatory agents, Current Opinion in Chemical Biology, 1999, 3, 4, 466

    CrossRef

  38. 38
    C. Schudt, F. Gantner, H. Tenors, A. Hatzelmann, Therapeutic Potential of Selective PDE Inhibitors in Asthma, Pulmonary Pharmacology & Therapeutics, 1999, 12, 2, 123

    CrossRef

  39. 39
    Bernadette Hughes, Gerry Higgs, New and Exploratory Therapeutic Agents for Asthma, 1999,

    CrossRef

  40. 40
    Matthew J. Peirce, Michael R. Munday, Peter T. Peachell, Characterization of protein serine/threonine phosphatase activities in human lung mast cells and basophils, British Journal of Pharmacology, 1998, 125, 5
  41. 41
    P T Peachell, S K Morcos, Effect of radiographic contrast media on histamine release from human mast cells and basophils., The British Journal of Radiology, 1998, 71, 841, 24

    CrossRef

  42. 42
    THEODORE J. TORPHY, Phosphodiesterase Isozymes, American Journal of Respiratory and Critical Care Medicine, 1998, 157, 2, 351

    CrossRef

  43. 43
    Marie C. Weston, Peter T. Peachell, Regulation of Human Mast Cell and Basophil Function by cAMP, General Pharmacology: The Vascular System, 1998, 31, 5, 715

    CrossRef